EUVIMEDEUVIMED entdecken
Leserbrief

Post‐Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia

Te-Fu Weng iD, Kang-Hsi Wu iD

Pediatric Blood & Cancer · 2026-10 · 73 (10)

DOI: 10.1002/1545-5017.70552 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 23.07.2026. Verfasst von Te-Fu Weng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

ORCID-Profile: Te-Fu Weng, Kang-Hsi Wu

Zitieren

APA

Weng, T. F., & Wu, K. H. (2026). Post‐Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70552

Vancouver

Weng TF, Wu KH. Post‐Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70552

BibTeX
@article{Weng2026,
  author = {Weng, Te-Fu and Wu, Kang-Hsi},
  title = {Post‐Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {10},
  doi = {10.1002/1545-5017.70552}
}
Kostenlos starten →